{
    "info": {
        "nct_id": "NCT03184870",
        "official_title": "A Phase 1b/2 Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors",
        "inclusion_criteria": "* Must have metastatic colorectal or pancreatic cancer\n* Eastern Cooperative Oncology Group (ECOG) performance status of ≤1\n* Ability to swallow pills or capsules\n* Required to undergo mandatory pre and on-treatment biopsies\n* Adequate marrow function\n* Adequate other organ functions\n* Ability to comply with study visits, treatment, procedures, pharmacokinetic (PK) and pharmacodynamic (PD) sample collection, and required study follow-up\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Histology other than adenocarcinoma (neuroendocrine or acinar cell)\n* Suspected, known, or central nervous system (CNS) metastases (Imaging required only if participants are symptomatic)\n* Active, known or suspected autoimmune disease\n* Condition requiring systemic treatment with either corticosteroids (> 10 mg daily prednisone equivalents) or other immunosuppressive medications within 14 days of study treatment administration\n* Interstitial lung disease that is symptomatic or may interfere with the detection or management of suspected treatment-related pulmonary toxicity\n* Prior treatment with cysteine-cysteine chemokine receptor 2 (CCR2) and/or cysteine-cysteine chemokine receptor 5 (CCR5) inhibitors, programmed death-1 receptor (PD-1), programmed death-ligand 1 [PD(L)-1] or cytotoxic T-lymphocyte antigen-4 (CTLA-4) antibodies\n* History of allergy to study treatments or any of its components of the study arm that participant is enrolling\n\nOther protocol-defined inclusion/exclusion criteria apply",
        "miscellaneous_criteria": "For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com"
    },
    "inclusion_lines": [
        {
            "line": "* Adequate marrow function",
            "criterions": [
                {
                    "exact_snippets": "Adequate marrow function",
                    "criterion": "marrow function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Must have metastatic colorectal or pancreatic cancer",
            "criterions": [
                {
                    "exact_snippets": "Must have metastatic colorectal or pancreatic cancer",
                    "criterion": "metastatic colorectal cancer",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Must have metastatic colorectal or pancreatic cancer",
                    "criterion": "metastatic pancreatic cancer",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Required to undergo mandatory pre and on-treatment biopsies",
            "criterions": [
                {
                    "exact_snippets": "Required to undergo mandatory pre and on-treatment biopsies",
                    "criterion": "biopsies",
                    "requirements": [
                        {
                            "requirement_type": "timing",
                            "expected_value": [
                                "pre-treatment",
                                "on-treatment"
                            ]
                        },
                        {
                            "requirement_type": "requirement",
                            "expected_value": "mandatory"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Adequate other organ functions",
            "criterions": [
                {
                    "exact_snippets": "Adequate other organ functions",
                    "criterion": "other organ functions",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Ability to comply with study visits, treatment, procedures, pharmacokinetic (PK) and pharmacodynamic (PD) sample collection, and required study follow-up",
            "criterions": [
                {
                    "exact_snippets": "Ability to comply with study visits",
                    "criterion": "compliance with study visits",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Ability to comply with ... treatment",
                    "criterion": "compliance with treatment",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Ability to comply with ... procedures",
                    "criterion": "compliance with procedures",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Ability to comply with ... pharmacokinetic (PK) and pharmacodynamic (PD) sample collection",
                    "criterion": "compliance with PK and PD sample collection",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Ability to comply with ... required study follow-up",
                    "criterion": "compliance with required study follow-up",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Ability to swallow pills or capsules",
            "criterions": [
                {
                    "exact_snippets": "Ability to swallow pills or capsules",
                    "criterion": "ability to swallow pills or capsules",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Eastern Cooperative Oncology Group (ECOG) performance status of ≤1",
            "criterions": [
                {
                    "exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status of ≤1",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1,
                                "unit": "N/A"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "Other protocol-defined inclusion/exclusion criteria apply",
            "criterions": [
                {
                    "exact_snippets": "Other protocol-defined inclusion/exclusion criteria apply",
                    "criterion": "other protocol-defined inclusion/exclusion criteria",
                    "requirements": [
                        {
                            "requirement_type": "applicability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior treatment with cysteine-cysteine chemokine receptor 2 (CCR2) and/or cysteine-cysteine chemokine receptor 5 (CCR5) inhibitors, programmed death-1 receptor (PD-1), programmed death-ligand 1 [PD(L)-1] or cytotoxic T-lymphocyte antigen-4 (CTLA-4) antibodies",
            "criterions": [
                {
                    "exact_snippets": "Prior treatment with cysteine-cysteine chemokine receptor 2 (CCR2) and/or cysteine-cysteine chemokine receptor 5 (CCR5) inhibitors",
                    "criterion": "prior treatment with CCR2 and/or CCR5 inhibitors",
                    "requirements": [
                        {
                            "requirement_type": "prior treatment",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Prior treatment with ... programmed death-1 receptor (PD-1) ... antibodies",
                    "criterion": "prior treatment with PD-1 antibodies",
                    "requirements": [
                        {
                            "requirement_type": "prior treatment",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Prior treatment with ... programmed death-ligand 1 [PD(L)-1] ... antibodies",
                    "criterion": "prior treatment with PD-L1 antibodies",
                    "requirements": [
                        {
                            "requirement_type": "prior treatment",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Prior treatment with ... cytotoxic T-lymphocyte antigen-4 (CTLA-4) antibodies",
                    "criterion": "prior treatment with CTLA-4 antibodies",
                    "requirements": [
                        {
                            "requirement_type": "prior treatment",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of allergy to study treatments or any of its components of the study arm that participant is enrolling",
            "criterions": [
                {
                    "exact_snippets": "History of allergy to study treatments",
                    "criterion": "allergy to study treatments",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "allergy to ... any of its components of the study arm that participant is enrolling",
                    "criterion": "allergy to components of study arm",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Condition requiring systemic treatment with either corticosteroids (> 10 mg daily prednisone equivalents) or other immunosuppressive medications within 14 days of study treatment administration",
            "criterions": [
                {
                    "exact_snippets": "Condition requiring systemic treatment with either corticosteroids (> 10 mg daily prednisone equivalents) or other immunosuppressive medications within 14 days of study treatment administration",
                    "criterion": "systemic treatment with corticosteroids",
                    "requirements": [
                        {
                            "requirement_type": "dose",
                            "expected_value": {
                                "operator": ">",
                                "value": 10,
                                "unit": "mg daily prednisone equivalents"
                            }
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": {
                                "operator": "<=",
                                "value": 14,
                                "unit": "days before study treatment administration"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Condition requiring systemic treatment with ... other immunosuppressive medications within 14 days of study treatment administration",
                    "criterion": "systemic treatment with other immunosuppressive medications",
                    "requirements": [
                        {
                            "requirement_type": "timing",
                            "expected_value": {
                                "operator": "<=",
                                "value": 14,
                                "unit": "days before study treatment administration"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Active, known or suspected autoimmune disease",
            "criterions": [
                {
                    "exact_snippets": "Active, known or suspected autoimmune disease",
                    "criterion": "autoimmune disease",
                    "requirements": [
                        {
                            "requirement_type": "activity status",
                            "expected_value": [
                                "active",
                                "known",
                                "suspected"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Interstitial lung disease that is symptomatic or may interfere with the detection or management of suspected treatment-related pulmonary toxicity",
            "criterions": [
                {
                    "exact_snippets": "Interstitial lung disease that is symptomatic",
                    "criterion": "interstitial lung disease",
                    "requirements": [
                        {
                            "requirement_type": "symptomatic",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Interstitial lung disease that ... may interfere with the detection or management of suspected treatment-related pulmonary toxicity",
                    "criterion": "interstitial lung disease",
                    "requirements": [
                        {
                            "requirement_type": "potential to interfere with detection or management of suspected treatment-related pulmonary toxicity",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Histology other than adenocarcinoma (neuroendocrine or acinar cell)",
            "criterions": [
                {
                    "exact_snippets": "Histology other than adenocarcinoma",
                    "criterion": "tumor histology",
                    "requirements": [
                        {
                            "requirement_type": "exclusion",
                            "expected_value": "adenocarcinoma"
                        }
                    ]
                },
                {
                    "exact_snippets": "neuroendocrine or acinar cell",
                    "criterion": "tumor histology",
                    "requirements": [
                        {
                            "requirement_type": "inclusion",
                            "expected_value": [
                                "neuroendocrine",
                                "acinar cell"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Suspected, known, or central nervous system (CNS) metastases (Imaging required only if participants are symptomatic)",
            "criterions": [
                {
                    "exact_snippets": "Suspected, known, or central nervous system (CNS) metastases",
                    "criterion": "central nervous system (CNS) metastases",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": [
        {
            "line": "For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com",
            "criterions": []
        }
    ]
}